NEW YORK (GenomeWeb News) – Roche Molecular Diagnostics this week said that its new Cobas p 630 Instrument has been launched with a CE Mark in Europe. The instrument is an automated, pre-analytical solution that is used with the firm's Amplilink 3.3 Series Software, which integrates the cobas p 630 with Roche's Cobas AmpliPrep Instruments and Cobas TaqMan Analyzers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.